Inflation Hasn’t Disappeared, Yet Chipotle (CMG) Raised Guidance
According to the latest economic reading, America’s GDP growth slowed to 1.5% in Q2 from 2.1% in Q1.
15 Stocks Beating Wall Street's Earnings Expectations
As many as three-quarters of S&P 500-member companies have already reported earnings in the second quarter of the year, with 85 percent exceeding analyst expectations and beating the 76 percent 10-year...
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Foresite bought 140,000 Latigo Biotherapeutics Inc. shares at $18.00
Samet bought 23,500 Adapthealth Corp. shares at $6.38
Wolf bought 20,000 Adapthealth Corp. shares at $5.86
Wolf bought 20,000 Adapthealth Corp. shares at $6.37
Tananbaum bought 140,000 Latigo Biotherapeutics Inc. shares at $18.00
Latest Insider Sales
Kreeger sold 31,159 Red Rock Resorts Inc. shares at $61.78
Albers sold 10,000 Spyre Therapeutics Inc. shares at $104.68
Albers sold 8,000 Spyre Therapeutics Inc. shares at $104.38
Albers sold 5,000 Spyre Therapeutics Inc. shares at $104.47
Discovery sold 500,000 Ramaco Resources Inc. shares at $9.57
Featured Content
Do not Miss
Margins Under Pressure, Demand Accelerating — Is TE Connectivity (TEL) at a Critical Inflection Point?
The accelerating AI infrastructure buildout, along with the ongoing electric vehicle adoption and industrial automation, is driving huge demand for electronic connectors and sensors. Expanding data center...
Jim Cramer Backs American Express (AXP) and Capital One (COF) as Consumer Spending Stays Strong
During the August 6 Mad Money episode, host Jim Cramer highlighted a change in consumer behavior that continues to benefit major credit card issuers.
Jim Cramer's AI Security Play: Why CrowdStrike (CRWD) and Palo Alto (PANW) Are Dominating the Market
Wall Street's early-year assumption that generative AI would commoditize cybersecurity led short sellers to bet heavily against specialized software platforms.
Jim Cramer Recommends Goldman Sachs and Morgan Stanley to Profit From Accelerating M&A Deals
Here's a big theme that right now really only impacts two large companies: pent-up demand for mergers and acquisitions now that the Biden era of overzealous antitrust enforcement has been replaced by ...
Jim Cramer Asks Why Constellation Brands (STZ) Stock Remains Cut in Half Despite Strong Earnings
During the August 6 episode of Mad Money, Jim Cramer focused his market analysis on the recent trajectory of Constellation Brands, Inc.
Jim Cramer Discusses Retailers He Likes: Williams-Sonoma (WSM) and Ralph Lauren (RL)
During the August 6 episode of Mad Money, host Jim Cramer highlighted the power of investing in strong retail themes supported by resilient consumers.
Jim Cramer Endorses Lockheed Martin as "Sensational"
During the lightning round of the August 6 episode of Mad Money, a caller inquired about the long-term outlook for Lockheed Martin Corporation (NYSE:LMT), highlighting its prominent position as a major...
Jim Cramer Flags Thomson Reuters (TRI) as a Value Trap
Man, that stock is always cheap, and that's the problem. It's like a value trap. I think maybe it could bounce a little bit.
Jim Cramer Picks CoreWeave (CRWV) as the Better Buy Over IREN
When a caller asked about IREN Limited (NASDAQ:IREN) during the lightning round of the August 6 episode of Mad Money, Jim Cramer remarked, “If you like IREN… you got to go buy CoreWeave.
Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?
A landmark legal settlement in the biotech sector recently reshaped the financial trajectories of two key mRNA technology players: Arbutus Biopharma Corporation (NASDAQ:ABUS) and Moderna, Inc.
Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks?
It was reported on July 27 that AstraZeneca PLC (NASDAQ:AZN) shares outperformed in European trading after the company reported second-quarter earnings that beat Wall Street expectations and reiterated...
Why the Amlitelimab Setback Isn't Enough to Sink Sanofi's Multi-Billion Dollar Engine
It was reported on July 24 that Sanofi (NASDAQ:SNY) shares underperformed in European trading following the company’s decision to drop the clinical development of its eczema candidate, amlitelimab, ...
Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?
Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space.
Synopsys (SNPS) Just Locked Into Intel's (INTC) Next Chip Node. What's The Payoff?
Synopsys (NASDAQ:SNPS) just extended its grip on the leading edge of chipmaking.
Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts’ average estimate of around...
Cloudflare (NET) Just Landed Washington, So Why Are Losses Widening?
On August 10, Cloudflare (NYSE:NET) announced that Cloudflare for Government achieved FedRAMP High authorization and GovRAMP Moderate authorization, with the intent to pursue Department of Defense Impact...
Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America's New Drug Manufacturing Policies?
For years, investors have viewed Eli Lilly (NYSE:LLY) and Novo Nordisk (NYSE:NVO) through one lens: the race to dominate the booming obesity-drug market.
MercadoLibre (MELI) Just Broke $10B, So Why Did Shares Sink?
MercadoLibre (NASDAQ:MELI) delivered something it had never done before on August 5: quarterly revenue topped $10 billion.
Tenet Healthcare’s (THC) Turnaround Is Working, but Can Its Growth Last?
Tenet Healthcare Corporation (NYSE:THC) has quietly become one of the strongest-performing healthcare stocks in the market, surging more than 270% over the past five years.
Can Johnson Controls (JCI) Turn Wasted Heat Into $18B?
Johnson Controls International (NYSE:JCI) just found a way to sell power that the data center industry was throwing away.
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
AbCellera Biologics Inc.
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
The obesity-drug market has largely been viewed as a race between clinical innovation and commercial execution.
Intel (INTC) Tripled This Year, But Can a $15B Share Sale Stop the Momentum?
Intel (NASDAQ:INTC) shares have nearly tripled this year, outrunning AMD (NASDAQ:AMD), Nvidia (NASDAQ:NVDA), and the Philadelphia Semiconductor Index's nearly 75% climb.
Abbott vs. Thermo Fisher: Is Diversification or the Life Sciences Recovery the Better Bet?
Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices...
American Airlines vs. Ryanair: Which Airline Is Better Positioned to Navigate Higher Fuel Costs?
American Airlines Group Inc. (NASDAQ:AAL) and Ryanair Holdings plc (NASDAQ:RYAAY) are facing the same industry-wide challenge: surging fuel costs.
Intuitive Surgical (ISRG) Just Beat Earnings. Is the Stock Still Worth Paying a Premium?
Intuitive Surgical (NASDAQ:ISRG) beat both top- and bottom-line consensus estimates in its fiscal Q2 2026 results, with revenue for the quarter growing 19% to $2.89 billion and adjusted EPS of $2.80 exceeding...
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about $25.05 billion.
GE Vernova (GEV) Wind Orders Rise Even As India Trims Doubts
GE Vernova (NYSE:GEV) added another Indian wind order to its books on August 4, agreeing to supply 43 onshore turbines to Enfinity Global for the 163.4 megawatt Fatehgarh Wind Farm in Rajasthan.
Gate DexBuilder Launches First Event Contracts Builder, Unveils $3 Million Grant Program to Accelerate Market Ecosystem
Gate, a leading global digital asset platform, today announced that Gate DexBuilder, its DEX infrastructure platform, has officially launched its first Event Contracts Builder, alongside a $3 million ...
Datadog (DDOG) Grows Fast, Then Gets Punished For Slowing Down
Datadog (NASDAQ:DDOG) just posted one of its strongest quarters in years on July 22, and the stock fell 19% anyway.
Apple (AAPL) Downgraded as Soaring Memory Costs Test iPhone Pricing Power
Tim Cook recently acknowledged that consumers should expect to pay higher prices for Apple products in the near-future as the company can no longer absorb surging costs for memory and storage components...
DoorDash (DASH) Powers Through Growth With Costs Rising Too
DoorDash (NASDAQ:DASH) released its second quarter 2026 financial results on August 5, and the headline numbers moved in the right direction almost across the board.
Coupang's (CPNG) Sales Keep Climbing While Its Profits Take A Hit
Coupang Inc. (NYSE:CPNG) reported results on August 4 for the quarter ended June 30, and its two headline numbers point in opposite directions.
Bloom Energy (BE) Expands Its Reach Into AI Manufacturing Power
Bloom Energy (NYSE:BE) just added another name to its growing list of AI infrastructure customers.
Hedge Fund Resource Center Lists
11 Largest Uranium Producing Countries in the World
5 Largest Uranium Producing Countries in the World
12 Cheapest Cigarette Brands in 2026
5 Cheapest Cigarette Brands in 2026
12 Best Cheap Colognes for Men That Smell Amazing
12 Fastest Declining Economies in the World in 2026
5 Fastest Declining Economies in the World in 2026
10 Most Popular Stocks on Robinhood in 2026
25 Countries with the Highest Debt to GDP Ratios
15 States with the Most Gun Violence in the US
9 Undervalued Chemical Stocks to Buy According to Hedge Funds
7 Most Promising Psychedelic Stocks According to Hedge Funds
7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds
15 Innovative Healthcare Stocks to Buy According to Analysts
9 High Growth Small Cap Stocks That Are Profitable
20 Most Profitable Stocks of the Last 20 Years
15 High Growth Mid-Cap Stocks to Buy
Top 10 Oncology Stocks to Buy Now
10 Best Investments During A Recession
7 Best Rare Earth Stocks to Buy According to Hedge Funds
Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending
New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)
J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum
11 Best Cancer Stocks to Buy Right Now
40 Most Unfriendly Countries in the World
30 Unhappiest Countries in the World in 2025
Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut
5 Countries with the Most Beautiful Women in the World
20 Countries with the Most Beautiful Women in the World
20 US Cities with the Highest Homeless Population Per Capita
20 Countries with the Highest Homeless Population
12 Countries with the Highest Bond Yields in the World
20 Countries with the Most Battle Tanks in the World
12 Best Nasdaq Stocks Under $20 to Buy Now
10 Best Low Beta Tech Stocks to Buy According to Analysts
10 Worst Performing Currencies of 2024
15 States with the Best Weed in America
16 Countries with the Largest Proven Oil Reserves in the World
16 Highest Quality Chocolate Brands in the US
20 Countries with the Strongest Armies in the World
Top 13 English Speaking Countries in Asia
20 States with Highest Female to Male Ratio in the US
40 Best Places to Visit in Europe Before You Die
20 States with the Lowest Life Expectancy in the US
25 Cities with the Highest Homeless Population in the World
20 Countries With The Best English Accent in The World
30 Cities with the Highest Weed Consumption in the US
25 Countries with the Highest Alcohol Consumption per Capita
10 Best Gold Stocks Under $30
10 Best Genomics Stocks To Buy Right Now
